Although several FD-specific iPSC lines have been obtained from patients carrying different GLA gene mutations, which claimed to be useful for FD cardiomyopathy research [9,10], one major limitation of such approach is the influence of variable genetic background, which can be significant even for monogenic, dominant and highly penetrant disease in FD [11,12]. This evidence concerns the gene GLA and Fabry disease.